NK cells: elusive players in autoimmunity

Yokoyama, 2004, The dynamic life of natural killer cells, Annu. Rev. Immunol., 22, 405, 10.1146/annurev.immunol.22.012703.104711 Rosmaraki, 2001, Identification of committed NK cell progenitors in adult murine bone marrow, Eur. J. Immunol., 31, 1900, 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M Lanier, 2005, NK Cell Recognition, Annu. Rev. Immunol., 23, 225, 10.1146/annurev.immunol.23.021704.115526 Colucci, 2002, Natural killer cell activation in mice and men: different triggers for similar weapons?, Nat. Immunol., 3, 807, 10.1038/ni0902-807 Cooper, 2004, NK cell and DC interactions, Trends Immunol., 25, 47, 10.1016/j.it.2003.10.012 Kronenberg, 2005, Toward an understanding of NKT cell biology: progress and paradoxes, Annu. Rev. Immunol., 23, 877, 10.1146/annurev.immunol.23.021704.115742 Carnaud, 1999, Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells, J. Immunol., 163, 4647, 10.4049/jimmunol.163.9.4647 Ljunggren, 1990, In search of the ‘missing self’: MHC molecules and NK cell recognition, Immunol. Today, 11, 237, 10.1016/0167-5699(90)90097-S Andre, 1996, Checkpoints in the progression of autoimmune disease: lessons from diabetes models, Proc. Natl. Acad. Sci. U. S. A., 93, 2260, 10.1073/pnas.93.6.2260 Takahashi, 2004, The regulatory role of natural killer cells in multiple sclerosis, Brain, 127, 1917, 10.1093/brain/awh219 Takahashi, 2001, Natural killer type 2 bias in remission of multiple sclerosis, J. Clin. Invest., 107, R23, 10.1172/JCI11819 Loza, 2002, Expression of type 1 (interferon γ) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells, Blood, 99, 1273, 10.1182/blood.V99.4.1273 Zhang, 1997, Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells, J. Exp. Med., 186, 1677, 10.1084/jem.186.10.1677 Matsumoto, 1998, Role of natural killer cells and TCR γδ T cells in acute autoimmune encephalomyelitis, Eur. J. Immunol., 28, 1681, 10.1002/(SICI)1521-4141(199805)28:05<1681::AID-IMMU1681>3.0.CO;2-T Smeltz, 1999, Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity, J. Immunol., 163, 1390, 10.4049/jimmunol.163.3.1390 Watanabe-Fukunaga, 1992, Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature, 356, 314, 10.1038/356314a0 Yabuhara, 1996, A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus, J. Rheumatol., 23, 171 Erkeller-Yusel, 1993, Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus, Lupus, 2, 227, 10.1177/096120339300200404 Scribner, 1988, The role of splenic colony-forming units in autoimmune disease, Clin. Immunol. Immunopathol., 49, 133, 10.1016/0090-1229(88)90102-X Takeda, 1993, The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms, J. Exp. Med., 177, 155, 10.1084/jem.177.1.155 Lee, 2004, Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells, J. Immunol., 172, 937, 10.4049/jimmunol.172.2.937 Todd, 2004, Deficiencies in gut NK cell number and function precede diabetes onset in BB rats, J. Immunol., 172, 5356, 10.4049/jimmunol.172.9.5356 Shi, 2000, Natural killer cells determine the outcome of B cell-mediated autoimmunity, Nat. Immunol., 1, 245, 10.1038/79792 Shi, 2000, IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells, J. Immunol., 165, 3099, 10.4049/jimmunol.165.6.3099 Vollmer, 2005, Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen, J. Immunol., 174, 2696, 10.4049/jimmunol.174.5.2696 Strengell, 2003, IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells, J. Immunol., 170, 5464, 10.4049/jimmunol.170.11.5464 Flodström, 2002, Target cell defense prevents the development of diabetes after viral infection, Nat. Immunol., 3, 373, 10.1038/ni771 Gonzalez, 1997, Genetic control of diabetes progression, Immunity, 7, 873, 10.1016/S1074-7613(00)80405-7 Poirot, 2004, Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity, Proc. Natl. Acad. Sci. U. S. A., 101, 8102, 10.1073/pnas.0402065101 Rolstad, 1986, Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL), J. Immunol., 136, 2800, 10.4049/jimmunol.136.8.2800 Biron, 1983, Increase in NK cell number and turnover rate during acute viral infection, J. Immunol., 131, 1539, 10.4049/jimmunol.131.3.1539 Taniguchi, 1987, Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens, Proc. Natl. Acad. Sci. U. S. A., 84, 3405, 10.1073/pnas.84.10.3405 Fehniger, 2003, CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity, Blood, 101, 3052, 10.1182/blood-2002-09-2876 Ferlazzo, 2004, The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic, J. Immunol., 172, 1455, 10.4049/jimmunol.172.3.1455 Ferlazzo, 2004, Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs, Proc. Natl. Acad. Sci. U. S. A., 101, 16606, 10.1073/pnas.0407522101 Freud, 2005, A human CD34+ subset resides in lymph nodes and differentiates into CD56bright natural killer cells, Immunity, 22, 295, 10.1016/j.immuni.2005.01.013 Cooper, 2001, Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset, Blood, 97, 3146, 10.1182/blood.V97.10.3146 Martin-Fontecha, 2004, Induced recruitment of NK cells to lymph nodes provides IFN-γ for T(H)1 priming, Nat. Immunol., 5, 1260, 10.1038/ni1138 Natuk, 1987, Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication, J. Immunol., 138, 877, 10.4049/jimmunol.138.3.877 Albertsson, 2003, NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity, Trends Immunol., 24, 603, 10.1016/j.it.2003.09.007 Dalbeth, 2002, A subset of natural killer cells is greatly expanded within inflamed joints, Arthritis Rheum., 46, 1763, 10.1002/art.10410 Tak, 1994, Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue, Arthritis Rheum., 37, 1735, 10.1002/art.1780371205 Traugott, 1985, Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions, Springer Semin. Immunopathol., 8, 71, 10.1007/BF00197248 Miyazaki, 1985, Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study, Clin. Exp. Immunol., 60, 622 Cameron, 2002, Natural killer and natural killer-T cells in psoriasis, Arch. Dermatol. Res., 294, 363, 10.1007/s00403-002-0349-4 Hori, 2003, Control of autoimmunity by naturally arising regulatory CD4+T cells, Adv. Immunol., 81, 331, 10.1016/S0065-2776(03)81008-8 Ferlazzo, 2002, Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells, J. Exp. Med., 195, 343, 10.1084/jem.20011149 Gerosa, 2002, Reciprocal activating interaction between natural killer cells and dendritic cells, J. Exp. Med., 195, 327, 10.1084/jem.20010938 Piccioli, 2002, Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells, J. Exp. Med., 195, 335, 10.1084/jem.20010934 Hayakawa, 2004, NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy, J. Immunol., 172, 123, 10.4049/jimmunol.172.1.123 Della Chiesa, 2005, Pathogen-induced private conversations between natural killer and dendritic cells, Trends Microbiol., 13, 128, 10.1016/j.tim.2005.01.006 Moretta, 2002, Natural killer cells and dendritic cells: rendezvous in abused tissues, Nat. Rev. Immunol., 2, 957, 10.1038/nri956 Tay, 1997, Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells, J. Virol., 71, 267, 10.1128/JVI.71.1.267-275.1997 Lauwerys, 2000, Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18, J. Immunol., 165, 1847, 10.4049/jimmunol.165.4.1847 Lauwerys, 1999, Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18, Cytokine, 11, 822, 10.1006/cyto.1999.0501 Chakir, 2001, Cytokine expression by murine DX5+ cells in response to IL-12, IL-18, or the combination of IL-12 and IL-18, Cell. Immunol., 212, 71, 10.1006/cimm.2001.1844 Li, 2005, Cutting Edge: in vivo blockade of human IL-2 receptor induces expansion of CD56bright regulatory NK cells in patients with active uveitis, J. Immunol., 174, 5187, 10.4049/jimmunol.174.9.5187 Gray, 1994, The role of transforming growth factor β in the generation of suppression: an interaction between CD8+T and NK cells, J. Exp. Med., 180, 1937, 10.1084/jem.180.5.1937 Horwitz, 1999, Role of NK cells and TGF-β in the regulation of T-cell-dependent antibody production in health and autoimmune disease, Microbes Infect., 1, 1305, 10.1016/S1286-4579(99)00253-1 Perussia, 2005, Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell, Mol. Immunol., 42, 385, 10.1016/j.molimm.2004.07.017 Cooper, 2001, The biology of human natural killer-cell subsets, Trends Immunol., 22, 633, 10.1016/S1471-4906(01)02060-9 Johansson, 2004, Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro, Int. Immunol., 16, 1, 10.1093/intimm/dxh002 Ogasawara, 2003, Impairment of NK cell function by NKG2D modulation in NOD mice, Immunity, 18, 41, 10.1016/S1074-7613(02)00505-8 Vitale, 2004, The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-γ production upon interaction with dendritic cells, Eur. J. Immunol., 34, 1715, 10.1002/eji.200425100 Martin, 2002, Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles, J. Immunol., 169, 2818, 10.4049/jimmunol.169.6.2818 Momot, 2004, Association of killer cell immunoglobulin-like receptors with scleroderma, Arthritis Rheum., 50, 1561, 10.1002/art.20216 Nelson, 2004, Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis, J. Immunol., 173, 4273, 10.4049/jimmunol.173.7.4273 Suzuki, 2004, Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to Psoriasis vulgaris, J. Invest. Dermatol., 122, 1133, 10.1111/j.0022-202X.2004.22517.x Yen, 2001, Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis, J. Exp. Med., 193, 1159, 10.1084/jem.193.10.1159 Dowdell, 2003, NK cells regulate CD4 responses prior to antigen encounter, J. Immunol., 171, 234, 10.4049/jimmunol.171.1.234